Receptors have a critical role in regulating lung function in health and disease.' Several such receptors have recently been sequenced, cloned, and genetically expressed. This opens up new vistas for investigating receptor regulation in pulmonary cells, for identifying receptor subtypes, and for understanding how disease may affect these regulatory processes. In the future it may also lead to new and more specific therapeutic approaches.
Receptor cloning
The genes for many neurotransmitter receptors have now been cloned. Several strategies have been used to isolate these DNA clones. Usually a DNA library prepared by partial digestion of genomic DNA from a tissue known to express the receptor is screened by using a labelled synthetic probe that is a part of the predicted DNA sequence of the receptor. Alternatively, a DNA probe is prepared with the aid of reverse transcriptase from messenger RNA (mRNA) extracted from a tissue expressing the receptor.
Once the receptor DNA or cDNA (that is, the complementary DNA produced from mRNA) is identified it can be inserted into a suitable vector (such as a plasmid) and then amplified (copied) in a suitable bacterial strain (usually a non-pathogenic strain of Escherichia coli), so that large numbers of exact copies may be made. This yields enough pure cDNA for the nucleotide sequence to be determined, leading to prediction of the amino acid sequence of the receptor.
Because there are structural similarities be- difficult to obtain a sufficient quantity of the receptor for the initial sequencing necessary to prepare a probe. More recently, the polymerase chain reaction has been used to amplify the number of mRNA copies in a cell in order to make a series of probes that can then be used to screen a DNA library. 3 The receptor DNA can also be inserted into an immortal cell line, resulting in its expression and thus providing a source of the receptor, so that the gene product can be characterised pharmacologically. The DNA may be microinjected directly into the large Xenopus (toad) oocyte, or transfected into a cultured mammalian cell that does not normally express the receptor by using a plasmid expression vector (ring of self replicating DNA into which the receptor DNA sequence of interest has been inserted), which after suitable manipulation inserts the DNA into the cultured cell genome. Cultured Chinese hamster ovary (CHO) and B-82 (a mouse L cell line) cells have been found to be very useful for studying neurotransmitter receptors because they lack these receptors but possess other elements such as G proteins and adenylyl cyclase, so that aspects of receptor coupling can be investigated. The cultured cells express the single receptor coded by the inserted DNA and this can be studied directly by radioligand binding and by measuring cellular responses, such as cyclic AMP concentrations or phosphoinositide hydrolysis. With the aid of a series of suitable agonists and antagonists the pure cloned receptor can then be characterised pharmacologically. Factors that influence the pure receptor can then be studied in detail without variations in metabolism and the interfering effects of related receptors.
Molecular structure of receptors G PROTEIN LINKED RECEPTORS
Although neurotransmitter receptors vary widely in terms of specificity for agonists, molecular biological characterisation has recently revealed some common structural features. This is perhaps understandable because all these receptors interact with a guanine nucleotide regulatory protein (G protein). to the formation of inositol (1, 4, 5) trisphosphate, the intracellular messenger that releases calcium ions from internal stores. 5 More than 20 G protein linked receptors have now been cloned and their sequences determined. 67 The first characterised receptor in this category was rhodopsin in light sensitive rods of the retina, which is linked to a unique G protein called transducin8 9; this has served as a useful model for other receptors in this group, which were cloned subsequently. Analysis of the amino acid sequence of rhodopsin has shown that seven hydrophobic (lipophilic) stretches of 20-25 amino acids are linked to hydrophilic regions of variable length. The most likely spatial arrangement of the receptor in the cell surface membrane is for the seven hydrophobic sections (each of which is in the form of an a helix) to span the cell membrane. The intervening hydrophilic sections are exposed alternately intracellularly and extracellularly with the amino (N) terminal end exposed to the outside and the carboxy (C) terminal end within the cytoplasm (fig 1) . The extracellular regions of rhodopsin recognise the appropriate ligand (retinal) and the intracellular regions interact with the relevant G protein (transducin).
Several other G protein linked receptors have now been cloned and sequenced. These include beta1,'0 beta2," 12 alpha,313 and alpha214 15 adrenoceptors; muscarinic receptors'6 9; and tachykinin receptors.2021 These receptors have the common feature of seven similar hydrophobic membrane spanning segments. There is also some sequence homology of the intracellular loops (which interact with various G proteins) but less similarity in the extracellular domain that recognises the different ligands. For example, there is a 50% homology between rat beta2 adrenergic and muscarinic M2 receptors. 22 There is also close homology between the same receptor in different species-for instance, there is 95% homology between rat and pig heart M2 22 receptors. These similarities support the view that the genes for G protein linked receptors form part of a superfamily that may have a common evolutionary origin.7
The receptors are generally 400-500 amino acids in length and the receptor DNA sequence consists of 2000-4000 nucleotide bases (2-4 kb). There is usually a striking lack of introns in the coding sequence of these receptors by comparison with genes for other proteins. The molecular weight of the cloned receptors predicted from the DNA sequence is 40 000-60 000 daltons (40-60 kDa), which is usually less than the molecular mass of the wild receptors when assessed by SDS polyacylamide gel electrophoresis. This discrepancy is due to glycosylation of the native receptor. For example, beta2 receptors contain two sites for glycosylation on asparagine (Asn/ N) residues near the amino terminus, and N glycosylation is estimated to account for 25-30O" of the molecular mass of the native receptor. The functional significance of glycosylation is not yet clear23; it does not affect receptor affinity for ligand or coupling to G proteins but may be important for the trafficking of the receptor through the cell during down regulation.
STEROID RECEPTORS
Cortisteroids interact with intracellular steroid receptors rather than surface receptors. There is a family of steroid receptors that recognise different endogenous steroids, such as glucocorticosteroids, mineralocorticoids, androgens, and oestrogens. Indeed, these steroid receptors also appear to be governed by a gene superfamily that also covers thyroid 24 hormone receptors. Steroid receptors have now been cloned and their structures have been shown to differ.2526 There is, however, some homology between these receptors because they all interact with nuclear DNA, where they act as modulators of the transcription of a specific network of genes. For instance, corticosteroids switch on the transcription of the 37 kDa protein lipocortin, which may inhibit phospholipase A2,27 though lipocortin is likely to be only one of several signal proteins induced by steroids.
The DNA binding domain of steroid receptors is rich in cysteine (Cys) residues. Formation of a complex with zinc folds the peptide chain into a finger shaped conformation, and the zinc is coordinated either by two Cys and two histidine or by four Cys residues. These "zinc fingers" appear to be essential for recognition of specific DNA sequences-the so called hormone response elements. 24 Understanding of the interactions between steroid receptors and DNA may enable synthetic agents to be developed that could mimic these responses. The steroid receptor-DNA interactions may be tissue specific and this opens up the possibility of developing more selective steroid like agents for therapeutic use, thereby reducing the potential hazards of systemic treatment.
Receptor subtypes
The existence of receptor subtypes is often first indicated by differences in the potency of a series of agonists in different tissues. This could be due to differing proportions of coexistent receptor subtypes, or may indicate the existence of a novel receptor subtype. Molecular biology can resolve these uncertainties because molecular techniques clearly discriminate between different subtypes of receptor and show that they are encoded by different genes. Thus the human beta, receptor is clearly different from the beta2 receptor in its amino acid sequence, with only a 54% homology,28 and the neurokinin 1 (NK-1) receptor, which is selectively activated by substance P, has 48% homology with the NK-2 receptor, which is activated by the related mammalian tachykinin neurokinin A. 21 Cross hybridisation in which a known receptor cDNA sequence is hybridised with a genomic library, has made it possible to detect previously unknown subtypes of a receptor. For example, an atypical beta receptor, which does not clearly fit into the beta, or beta2 subtypes, has been suspected in adipose tissue and recently the "beta3" receptor has been identified, cloned, sequenced and expressed.29 The beta3 receptor is clearly different from both beta, and beta2 receptors (about 50% amino acid sequence homology In Northern blot analysis the RNA is run on a size separation gel, and then hybridised with the labelled cDNA (or complementary RNA) probe to show whether there is a labelled band that corresponds to the receptor mRNA. Specific mRNA represents only a small percentage of total RNA and may be difficult to detect, especially when the amounts are small (which is usually the case for receptor mRNA). The mRNA that is transcribed, however, is characterised by a long polyadenine (poly(A)) tail and it is therefore possible to extract such mRNA selectively with column chromatography by using the complementary polydeoxythymidine (poly(dT)). The poly(A) tail of mRNA hybridises with the complementary poly(dT)) on the column and is thus retained while the other RNA molecules pass through. The mRNA can subsequently be harvested for study.
With this approach the distribution of muscarinic receptor subtype mRNAs has been determined in different tissues. This indicates that both m2 and m3 receptors are found in porcine and rat tracheal smooth muscle.48 Beta2 receptor mRNA has also been detected in human and rat lung49 and in guinea pig lung mast cells. 50 
